ZTEK
Zentek Ltd.
NASDAQ · Healthcare · Medical - Instruments & Supplies · CA
$0.49
+0.00%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 108.3K | 166.5K | 872.5K | 29.8K | 72.9K |
| Cost of Revenue | 5.5M | 6.5M | 680.0K | 331.1K | 853.3K |
| Gross Profit | (5.4M) | (6.3M) | 192.5K | (301.3K) | (780.5K) |
| Operating Expenses | |||||
| R&D Expense | 1.8M | 1.7M | 465.7K | 1.8M | 1.6M |
| SG&A Expense | 5.6M | 2.9M | 8.0M | 8.9M | 11.0M |
| General & Admin Expense | 3.6M | — | 7.9M | 8.6M | 10.6M |
| Selling & Marketing Expense | 1.3M | — | 105.4K | 375.6K | 368.4K |
| Other Expenses | (1.9M) | 26.5K | 1.3M | 956.7K | 1.2M |
| Total Operating Expenses | 5.5M | 4.6M | 9.8M | 11.7M | 13.9M |
| Cost and Expenses | 11.0M | 11.0M | 10.5M | 12.0M | 14.7M |
| Operating Income (EBIT) | (10.9M) | (10.9M) | (9.6M) | (12.0M) | (14.7M) |
| Non-Operating | |||||
| Interest Income | 54.0K | 40.4K | 101.6K | 405.5K | 510.3K |
| Interest Expense | 300.3K | 290.0K | 91.3K | 107.4K | 120.6K |
| Net Interest Income | (246.2K) | (249.6K) | 10.3K | 298.1K | 389.6K |
| Other Non-Op Income/Expense | 436.0K | 1.1M | (439.0K) | 174.7K | 238.7K |
| Non-Operating Income (excl Interest) | 202.9K | — | 347.7K | (282.1K) | (359.3K) |
| EBT (Pre-Tax Income) | (10.5M) | (9.8M) | (10.0M) | (11.8M) | (14.4M) |
| Income Tax Expense | — | — | — | (99.8K) | — |
| Bottom Line | |||||
| Net Income | (10.5M) | (9.8M) | (10.0M) | (11.7M) | (14.4M) |
| Earnings from Cont. Ops | (10.5M) | (9.8M) | (10.0M) | (11.7M) | (14.4M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (10.5M) | (9.8M) | (10.0M) | (11.7M) | (14.4M) |
| Per Share | |||||
| Basic EPS | ($0.09) | ($0.09) | ($0.10) | ($0.12) | ($0.14) |
| Diluted EPS | ($0.09) | ($0.09) | ($0.10) | ($0.12) | ($0.14) |
| Revenue Per Share | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 115.4M | 105.9M | 103.0M | 97.5M | 99.4M |
| Diluted Shares Outstanding | 115.4M | 105.9M | 103.0M | 100.5M | 99.4M |
| Profitability Metrics | |||||
| EBITDA | (10.6M) | (10.3M) | (9.3M) | (11.1M) | (13.8M) |
| D&A | 478.9K | 527.8K | 600.3K | 613.7K | 539.7K |
| EBIT | (11.1M) | (10.9M) | (9.9M) | (11.7M) | (14.3M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026